These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9484873

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Cranfield R, Breisch S, Pettit R.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Zuck P, Vogel F, McIvor A, Peirzchala W, Smakal M, Staley H, Marr C.
    J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, DeAbate CA, Haverstock D, Aneiro L, Church D.
    Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475
    [Abstract] [Full Text] [Related]

  • 10. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
    Klietmann W, Cesana M, Rondel RK, Focht J.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2298-306. PubMed ID: 8285609
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Theophylline and warfarin interaction studies with grepafloxacin.
    Efthymiopoulos C, Bramer SL, Maroli A, Blum B.
    Clin Pharmacokinet; 1997 Nov; 33 Suppl 1():39-46. PubMed ID: 9433655
    [Abstract] [Full Text] [Related]

  • 18. Grepafloxacin.
    Wagstaff AJ, Balfour JA.
    Drugs; 1997 May; 53(5):817-24; discussion 825-7. PubMed ID: 9129868
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
    Efthymiopoulos C, Bramer SL, Maroli A.
    Clin Pharmacokinet; 1997 May; 33 Suppl 1():1-8. PubMed ID: 9433650
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial activity of grepafloxacin.
    Wiedemann B, Heisig P.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():19-25. PubMed ID: 9484869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.